SLIDE-VIP: a comprehensive, cell line- and patient-based framework for synthetic lethality prediction in DNA damage repair, chromatin remodeling and cell cycle
Markowska, M.; Budzinska, M. A.; Coenen-Stass, A.; Kang, S.; Kizling, E.; Kolmus, K.; Koras, K.; Staub, E.; Szczurek, E.
Show abstract
Discovering synthetic lethal (SL) gene partners of cancer genes is an important step in developing cancer therapies. However, identification of SL interactions is challenging, due to a large number of possible gene pairs, inherent noise and confounding factors in the observed signal. To discover robust SL interactions, we devised SLIDE-VIP, a novel framework combining eight statistical tests, including a new patient data-based test iSurvLRT. SLIDE-VIP leverages multi-omics data from four different sources: gene inactivation cell line screens, cancer patient data, drug screens and gene pathways. We applied SLIDE-VIP to discover SL interactions between genes involved in DNA damage repair, chromatin remodeling and cell cycle, and their potentially druggable partners. The top 883 ranking SL candidates had strong evidence in cell line and patient data, 250-fold reducing the initial space of 200K pairs. Drug screen and pathway tests provided additional corroboration and insights into these interactions. We rediscovered well-known SL pairs such as RB1 and E2F3 or PRKDC and ATM, and in addition, proposed strong novel SL candidates such as PTEN and PIK3CB. In summary, SLIDE-VIP opens the door to the discovery of SL interactions with clinical potential. All analysis and visualizations are available via the online SLIDE-VIP WebApp.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing 97%
- Random Walk with Restart on multilayer networks: from node prioritisation to supervised link prediction and beyond 96%
- driveR: A Novel Method for Prioritizing Cancer Driver Genes Using Somatic Genomics Data 95%
Similar papers in this journal
- APSiC: Analysis of Perturbation Screens for the Identification of Novel Cancer Genes 95%
- Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of the gene regulatory program in cancers 94%
- DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal 94%
Similar papers in this journal
- Uncovering Hidden Cancer Self-Dependencies through Analysis of shRNA-Level Dependency Scores 97%
- Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell lines 95%
- Genome-wide investigation of gene-cancer associations for the prediction of novel therapeutic targets in oncology 95%
Similar papers in this journal
- SLAYER: A Computational Framework for Identifying Synthetic Lethal Interactions through Integrated Analysis of Cancer Dependencies 96%
- Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer 95%
- Prognostic importance of splicing-triggered aberrations of protein complex interfaces in cancer 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.